Colchicine may reduce myocardial damage after non-bypass heart surgery.

Published Date: 17 Feb 2023

China: Low-dose colchicine helps protect myocardium in surgery patients without CABG (coronary artery bypass graft).

Read Full News

Latest News

Morphine Plus Acetaminophen May Boost Pain Relief in the ED

Intravenous morphine plus acetaminophen provides greater early pain reduction and requires fewer rescue doses than morphine alone in the emergency department, a trial finds.

Albumin Replacement Therapy Shows No Benefit in Septic Shock

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

Mar 13 2026 This Week in Cardiology

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the topics John Mandrola, MD, discusses in this week’s podcast.

How a Mom Uncovered a Hidden Driver of Childhood Eczema

New research reveals a clue in the persistent mystery of why eczema is so common in infancy.

The Unexpected Impact of TV Doctors on Patient Trust

From Dr Greene’s hubris to House’s Vicodin addiction to the traumatized doctors in The Pitt, could modern depictions of flawed physicians be doing more harm than good?

Lancet Commission Elevates Global Dermatology Priorities

For the first time, a Lancet Commission is shining a light on the global burden of skin diseases and spurring an action plan.

Todays Updates

Telemedicine Not Reaching Rural Psychiatric Patients

Telemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.

Shorter but More Intense RT: A Better Option for HNSCC?

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.

Todays Updates

Telemedicine Not Reaching Rural Psychiatric Patients

Telemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.

Shorter but More Intense RT: A Better Option for HNSCC?

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.

Latest News

Intravenous morphine plus acetaminophen provides greater early pain reduction and requires fewer rescue doses than morphine alone in the emergency department, a trial finds.

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the topics John Mandrola, MD, discusses in this week’s podcast.

New research reveals a clue in the persistent mystery of why eczema is so common in infancy.

From Dr Greene’s hubris to House’s Vicodin addiction to the traumatized doctors in The Pitt, could modern depictions of flawed physicians be doing more harm than good?

For the first time, a Lancet Commission is shining a light on the global burden of skin diseases and spurring an action plan.

News All Time

US Kidney Transplant Inequity Narrows for Black Patients

Black patients with failing kidneys are receiving more transplants and spending less time on transplant waiting lists, after decades in which ⁠race-based medical guidelines...

Futile CPR vs Supportive Care: How to Talk DNR

Doing CPR in dying patients with uncorrectable medical conditions is akin to operating on the wrong limb, writes John Mandrola, MD. If DNR conversations explain this better, would more patients sign up?

GLP-1 RAs Underused in Teens With Type 2 Diabetes

Insurance issues may be part of the problem, according to a new analysis.

APC Spending on Specialty Derm Drugs Rapidly Increasing

While a higher proportion of physicians are prescribing biologics, ‘the growth rate has been faster for APCs,’ one of the study authors said.

Vertex to Seek US Approval After Promising Late-stage Results for Kidney Drug

Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney ⁠damage in a late‑stage trial, putting the company on track to seek...

Risk Factors for Early Development of Food Allergies

The study found multiple childhood food allergy risk factors but no link to vaccines.

Extended Dupilumab Dosing Maintains Efficacy in Nasal Polyps

Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.

Doctors Raise Their Voices Against AMR

Healthcare professionals are stepping into the spotlight in Lifeline, a musical that blends medicine, music, and a warning about antimicrobial resistance.

Adrenocortical Carcinoma: Incidence and Survival Over Time

The incidence of adrenocortical carcinoma is stable over time, but the survival for stage IV disease has improved, with the centralisation of care being associated with better survival.

Immunoglobulin A Nephropathy: 5 Treatment Approaches to Know

The treatment landscape for IgA nephropathy is rapidly evolving, with therapies focused on mitigating the effects of nephron loss now being combined with immunomodulatory treatments.

Tolvaptan vs Fluid Limits: Do Costs Outweigh pNa Gains?

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection of sodium increases.

Pfizer's Eczema Drug Meets Main Goal in Mid-stage Trial, Plans Late-stage Study

U.S. drugmaker Pfizer said on Monday its experimental drug for a ⁠chronic skin disease met the main goal in a mid-stage study.

Outpatient RSV in Kids Younger Than 2 Has Distinct Features

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater illness burden than infections caused by other respiratory viruses.

Women at Higher Risk for Chronic Cough With Age

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

Gene Therapy Injections for Knee OA: Where Are We At?

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

FDA Approves Deucravacitinib as First TYK2 Inhibitor for PsA

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

Recommended News For You

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

FDA Authorizes Three Different Uses for Injectable Antibiotic.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

Recommended Articles For You

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources 

The Life-Saving Powers of Anemia: How to Combat the Disease. 

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis 

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss trial reports success for breast cancer patients at one year mark

2.

Lesser-known lobular breast cancer on the rise in U.S. women

3.

Guideline on management of early-stage non-small cell lung cancer released

4.

Medical Journal March 29, 2023

5.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

1.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

2.

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision

3.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

4.

Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology

5.

Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

2.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot